Treatment Strategies for Deficiency of Adenosine Deaminase 2.

Autor: Ombrello AK; National Human Genome Research Institute, Bethesda, MD ombrelloak@mail.nih.gov., Qin J; National Institute of Allergy and Infectious Diseases, Bethesda, MD., Hoffmann PM; National Human Genome Research Institute, Bethesda, MD., Kumar P; National Institutes of Health Clinical Center, Bethesda, MD., Stone D; National Human Genome Research Institute, Bethesda, MD., Jones A; National Human Genome Research Institute, Bethesda, MD., Romeo T; National Human Genome Research Institute, Bethesda, MD., Barham B; National Human Genome Research Institute, Bethesda, MD., Pinto-Patarroyo G; National Human Genome Research Institute, Bethesda, MD., Toro C; National Human Genome Research Institute, Bethesda, MD., Soldatos A; National Institute of Neurological Disorders and Stroke, Bethesda, MD., Zhou Q; National Human Genome Research Institute, Bethesda, MD., Deuitch N; National Human Genome Research Institute, Bethesda, MD., Aksentijevich I; National Human Genome Research Institute, Bethesda, MD., Sheldon SL; National Institutes of Health Clinical Center, Bethesda, MD., Kelly S; Duke University, Durham, NC., Man A; University of Manitoba, Winnipeg, MB, Canada., Barron K; National Institute of Allergy and Infectious Diseases, Bethesda, MD., Hershfield M; Duke University, Durham, NC., Flegel WA; National Institutes of Health Clinical Center, Bethesda, MD., Kastner DL; National Human Genome Research Institute, Bethesda, MD.
Jazyk: angličtina
Zdroj: The New England journal of medicine [N Engl J Med] 2019 Apr 18; Vol. 380 (16), pp. 1582-1584.
DOI: 10.1056/NEJMc1801927
Databáze: MEDLINE